The PCE Price Index year over year rose 2.6% in December, in line with forecasts and following an increase of 2.4% in ...

Progress on inflation was "noticeably" slower last year than in 2023, and upside risks to higher price pressures remain, and therefore the U.S. central bank should adopt a cautious and gradual ...

AbbVie saw fourth-quarter sales handily beat Wall Street's projections as gains from its newer anti-inflammatory drugs helped offset declines from Humira, once its best performing asset. The drugmaker ...

Bristol Myers on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Breyanzi for the treatment of adults with relapsed or refractory ...

Fortune magazine's annual ranking of the "world's most admired companies" - the latest of which was released this week - provides yet another object lesson in contrarian analysis. That's because ...

Oil futures ticked lower Friday and were on track for weekly losses as traders awaited a decision by President Donald Trump on tariffs on imports from Canada and Mexico.

Every player who wins the Super Bowl will get a $171,000 bonus from the NFL. Some stars will also get bonuses from their team of up to an additional. $1.5 million. The Kansas City Chiefs and the ...

AbbVie Inc.'s stock rose 4% early Friday, after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025.

Strategic alliances with companies like Palantir Technologies (PLTR) have expanded Azure's capabilities, particularly in delivering AI-based data analytics products to U.S. defense and intelligence ...

Merck on Friday said the recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use covers the 21-valent conjugate vaccine for immunization for the prevention ...

Colgate-Palmolive forecast 2025 sales to be roughly flat from last year; sales came in at $20.10 billion in 2024. Write to Denny Jacob at [email protected] ...

Colgate-Palmolive Co. (CL) shares are down 0.7% in premarket trades despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue ...